During the past decade, Ocala GI Research conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ocala GI Research" #1 sponsor was "Boehringer Ingelheim" with 1 trials, followed by "Enanta Pharmaceuticals, Inc" with 1 trials sponsored, "Freenome Holdings Inc." with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Hanmi Pharmaceutical Company Limited" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ocala GI Research" #1 collaborator was "Novo Nordisk A/S" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Ocala GI Research" are "Adenoma" (1 trials), "Colon Cancer" (1 trials), "Colon Diseases" (1 trials), "Colon Lesion" (1 trials) and "Colon Neoplasm" (1 trials). Many other conditions were trialed in "Ocala GI Research" in a lesser frequency.

Most popular intervention types in "Ocala GI Research" are "Drug" (4 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "BI 456906" (1 trials), "Cilofexor (CILO)/Firsocostat (FIR)" (1 trials), "EDP-305 1.5 mg" (1 trials) and "EDP-305 2 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ocala GI Research" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Ocala GI Research". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Ocala GI Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ocala GI Research, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".